CHGX — Chitogenx Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Chitogenx, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.49 | -3.77 | -4.92 | -6.23 | -1.55 |
| Depreciation | |||||
| Non-Cash Items | 0.782 | 1.45 | 1.26 | 1.52 | -1.21 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.003 | -0.752 | 0.368 | 1.46 | 1.71 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.59 | -2.98 | -3.22 | -3.2 | -1.01 |
| Capital Expenditures | 0 | -0.003 | -0.033 | 0 | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.003 | -0.033 | 0 | — |
| Financing Cash Flow Items | -0.077 | -0.173 | 0.074 | 0.618 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.37 | 5.05 | 1.16 | 2.94 | 0.937 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.222 | 2.08 | -2.07 | -0.205 | -0.073 |